JP2024525609A5 - - Google Patents

Info

Publication number
JP2024525609A5
JP2024525609A5 JP2024500475A JP2024500475A JP2024525609A5 JP 2024525609 A5 JP2024525609 A5 JP 2024525609A5 JP 2024500475 A JP2024500475 A JP 2024500475A JP 2024500475 A JP2024500475 A JP 2024500475A JP 2024525609 A5 JP2024525609 A5 JP 2024525609A5
Authority
JP
Japan
Application number
JP2024500475A
Other languages
Japanese (ja)
Other versions
JPWO2023283644A5 (https=
JP2024525609A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073566 external-priority patent/WO2023283644A2/en
Publication of JP2024525609A publication Critical patent/JP2024525609A/ja
Publication of JPWO2023283644A5 publication Critical patent/JPWO2023283644A5/ja
Publication of JP2024525609A5 publication Critical patent/JP2024525609A5/ja
Pending legal-status Critical Current

Links

JP2024500475A 2021-07-09 2022-07-08 Trop-2陽性癌を標的とするキメラ抗原受容体 Pending JP2024525609A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163220283P 2021-07-09 2021-07-09
US63/220,283 2021-07-09
PCT/US2022/073566 WO2023283644A2 (en) 2021-07-09 2022-07-08 Chimeric antigen receptor to target trop-2-positive cancers

Publications (3)

Publication Number Publication Date
JP2024525609A JP2024525609A (ja) 2024-07-12
JPWO2023283644A5 JPWO2023283644A5 (https=) 2025-07-07
JP2024525609A5 true JP2024525609A5 (https=) 2025-07-07

Family

ID=84802126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500475A Pending JP2024525609A (ja) 2021-07-09 2022-07-08 Trop-2陽性癌を標的とするキメラ抗原受容体

Country Status (10)

Country Link
US (1) US20240325444A1 (https=)
EP (1) EP4366747A4 (https=)
JP (1) JP2024525609A (https=)
KR (1) KR20240034220A (https=)
CN (1) CN117881407A (https=)
AU (1) AU2022306051A1 (https=)
CA (1) CA3224887A1 (https=)
IL (1) IL309497A (https=)
MX (1) MX2024000479A (https=)
WO (1) WO2023283644A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118265535A (zh) * 2021-10-20 2024-06-28 得克萨斯大学体系董事会 具有最佳信号传导的car构建体的工程化nk细胞
GB202318553D0 (en) * 2023-12-05 2024-01-17 Unikum Therapeutics Aps Engineered plasmacytoid dendritic cells
WO2025194098A1 (en) * 2024-03-14 2025-09-18 Dana-Farber Cancer Institute, Inc. Engineered immune cells expressing chimeric antigen receptors targeting trop2, and methods of using the same
CN119215188B (zh) * 2024-04-12 2025-09-05 英百瑞(杭州)生物医药有限公司 抗Trop2抗体和抗5T4抗体-自然杀伤细胞偶联物及其用途
CN118307680A (zh) * 2024-04-28 2024-07-09 华南农业大学 一种抗氯霉素单克隆抗体及其基于磁珠的自动化化学发光酶免疫检测方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074566A2 (en) * 2002-03-01 2003-09-12 Immunomedics, Inc. Rs7 antibodies
JP2018500930A (ja) * 2014-12-04 2018-01-18 アブルッツォ・セラノスティックス・エッセ・エッレ・エッレ ヒト化抗trop−2モノクローナル抗体及びその使用
CN107708741A (zh) * 2015-06-12 2018-02-16 免疫医疗公司 用嵌合抗原受体(car)构建体和表达car构建体的t细胞(car‑t)或nk细胞(car‑nk)进行的疾病疗法
US11951131B2 (en) * 2018-07-03 2024-04-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-SLAMF7 chimeric antigen receptors
BR112021003640A2 (pt) * 2018-08-31 2021-05-18 Noile-Immune Biotech, Inc. célula t, medicamento, vetor de expressão, e, métodos para produzir uma célula de t car e para tratar câncer
SG11202104524YA (en) * 2018-11-01 2021-05-28 Gracell Biotechnologies Shanghai Co Ltd Compositions and methods for t cell engineering
WO2023232746A1 (en) * 2022-05-30 2023-12-07 Mediterranea Theranostic S.R.L. Anti-activated trop-2 chimeric antigen receptor constructs for use in cancer therapy

Similar Documents

Publication Publication Date Title
JP2024525609A5 (https=)
BR102022025291A2 (https=)
CL2025003713S1 (es) Cierre para una estructura de rampas para maniobras vehiculares.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307047150S (https=)
BY13169U (https=)
CN307045815S (https=)
BY23963C1 (https=)
CN307045967S (https=)
CN307047032S (https=)
BY13176U (https=)